Member Info for 46Gillingham

Quadrise plc (AIM: QED), the technology company focused on the decarbonisation of shipping and heavy industry through deployment of low emission fuels and biofuels, is pleased to provide an update covering progress on its key projects.

Marine

The expected bilateral agreements between MSC and Cargill, and Cargill and Quadrise, to initiate the commercial-scale marine trials are now in near final form and are expected to be concluded soon. Following signature, the trial equipment will be installed and commissioned at the MAC2 site in Antwerp, ahead of the commercial-scale marine trials commencing in Q3 2025.

Quadrise continues to make strong progress in building strategic partnerships with additional potential customers, aimed at accelerating the commercialisation of bioMSAR™ and MSAR®. The Company intends to utilise its facilities at MAC2 to service these opportunities, as well as establishing similar supply points in other major marine bunker hubs.

Morocco

The planned commercial trial with OCP to establish MSAR® supply in the Mediterranean continues to progress. Following relocation to an alternative production line and associated kiln by OCP, the Company has deployed all necessary trial equipment to site. To commence the 30-day paid trial, Quadrise is awaiting approval from the original equipment manufacturer of the kiln and burner system ("OEM"), which is expected to be received in Q3 2025, with the trial commencing immediately thereafter.

In parallel, Quadrise and the OEM are exploring potential collaboration opportunities with other industrial clients.

Americas

In Panama, excellent progress continues to be made for our trial with Sparkle Power SA. Trial equipment and chemicals have been shipped to site, with the trial now expected to start during Q3 2025. This will be the first test for Quadrise on a MAN 4-stroke diesel engine, expanding our application experience with this significant engine manufacturer. A successful trial would be expected by the Company to lead to a Fuel Supply Agreement with a supplier and to facilitate discussions with other regional power producers.

US Low Carbon Fuels

Quadrise is now awaiting delivery of a new batch of oil samples from Valkor's Primary Project Site ('PPS') at Asphalt Ridge, Utah, USA as the previous samples tested were deemed unrepresentative of Valkor's expected final oil output. Once testing of these samples has been positively concluded, marketing of MSAR® and bioMSARTM fuels in the USA can then commence.

Quadrise now expects to deliver a smaller 600bpd Multifuel Manufacturing Unit ("MMU") to the PPS in Q3 2025, with the US$75k per quarter technology transfer fee payable by Valkor to Quadrise commencing from the date of delivery.

bioMSAR™ and bioMSAR™ Zero development

Quadrise continues to advance several joint development and commercial discussions and testing with potential partners and customers to deliver cleaner fuels at a lower cost than alternat

Ive read many different comments on Jason over the last few days....

My own thoughts are:-

I was pleased when he took the role of CEO

His presentation skills are good

Im also pleased we have a number of projects on the go

Ive been an ongoing supporter of both Him and Andy understanding their challenges over the years

However as CEO Jason has been continuously too optimistic on virtually all timelines over the last few years.

Some project seem dormant as they have been constantly paraded over the years with no real movement.

The share price in 2021 was circ 4p more of less were it is today, so we have seen no real growth and have had 4 funding all with with hopeful noise about the future each time.

Im still keeping everything crossed that some good news will be published in June

Im very hopeful still long term which is why I hold over 1% of the shares and if added to my colleagues we hold over 2%.

Slide 22

With SOx and other regulations, Marine fuel is costing

upwards of 200% of WTI

• Adding Glycerin and water and Quadrise process to this

no-sulfur oil creates a marine fuel product

Also Q2 expectations were a busy quarter with multiple RNS's covering all current projects with the exception of 1 April news we have had 9 weeks of silence.

Maersk logo very visable on one og the first slides

Jason still saying hopes to be profitable mid 2026

Team Growing

Confirmed still planned to Supply the Cargil/MSC project

Sorry-- in front of us

Am I dreaming or was Q2 going to be a very busy period with multiple updates across all our projects. With the exception of 1st April MAC2 agreement nothing....What do we have delays everywhere or a busy 6 weeks on front?

I've just looked at my filtered page 59 in total. Months ago I got feedup with many posters so everyday I just see a sea of green filtered posts which I dont have to read thank god, everyone has the same option filter or read

In accordance with section 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules (DTRs), the Company hereby notifies the market of the following:

The issued share capital of Quadrise as at 30 April 2025 consists of 1,986,695,465 ordinary shares of 1 pence each ("Ordinary Shares") with voting rights attached. Of these, no Ordinary Shares are held exclusive of voting rights in Treasury. Therefore, the total number of voting rights in Quadrise as at 30 April 2025 is 1,986,695,465.

Shareholders may use the figure of 1,986,695,465 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Quadrise under the DTRs.

Strengthening for Growth

Quadrise plc (AIM: QED), the energy transition technology company focused on the decarbonisation of shipping and heavy industry through deployment of low carbon fuels and biofuels, announces a planned reorganisation of its senior leadership team to support the Company as it scales up its commercial and technical activities, reflecting the accelerating momentum at Quadrise.

Jason Miles, Chief Executive Officer, will transition into a newly created role of Chief Technology Officer with effect from 1 June 2025. In this capacity, Jason will focus on accelerating the development and deployment of the Company's core technologies, including MSAR®, bioMSAR™ and bioMSAR™ Zero.

In particular, he will take full ownership of the ongoing commercial trials and associated technical programmes and partnerships which are of critical importance for the commercial evolution of the Company. Jason will continue to be a director on the board and will report to a new Chief Executive Officer, whom the Company has commenced a process to identify and appoint.

To enable Jason Miles to focus on his newly defined role, and to provide continuity and leadership ahead of the appointment of a new Chief Executive, Andy Morrison, Chairman of Quadrise, will take on additional executive duties on an interim basis with effect from 1 June 2025. Andy remains Chair of the board of directors.

In expanding the Board with a new CEO as an additional executive director, together with the CTO's enhanced focus on the deployment of the Company's technologies, the Board believes that leadership and execution capacity will be enhanced across the Company's major projects, enabling Quadrise to capture upcoming opportunities.

Further announcements regarding the CEO appointment process will be made, as appropriate, in due course.

Andy Morrison, Chair of Quadrise, commented:

Willswag I pray you are correct what a great prediction.

Most of the time Majors are happy to pay the full price later on once a business has been de-risked, rather than risk money on an unproven tech.

Barclays are having trading software problems today. I've had to put a complaint in this morning as my sell and buy had a 90 minute gap and a huge price difference

Ive managed to Sell 571,300 shares this morning from my Taxable portfolio......

Dealer is just trying to purchase them back now in my ISA

Quadrise Plc (AIM: QED), the transition technology provider for a cleaner planet, announces that as a result of an exercise of employee share options, application has been made for 4,314,249 new ordinary shares of 1 pence each in the Company (the "New Ordinary Shares") to be admitted to trading on AIM.

The New Ordinary Shares will rank pari passu with the Company's existing ordinary shares and it is expected that admission will occur at 8.00 a.m. on 8 April 2025.

Following admission of the New Ordinary Shares, the Company's issued ordinary share capital will comprise 1,986,696,165 ordinary shares, none of which are held in treasury. Therefore, the total number of ordinary shares with voting rights in Quadrise following admission will be 1,986,696,165.

The above figure of 1,986,696,165 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For additional information, please contact:

Https://www.lse.co.uk/research/QED/making-waves-5p81qn8f06xfd6m.html

Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to announce the signature of a Services Supply Agreement ("Agreement") with MAC2 Solutions NV ("MAC2") with regard to the production of MSAR® and bioMSAR™ fuels for the Company's forthcoming marine vessel trials on board the MSC Leandra V, expected to commence in Q2 2025 (the "Trials").

The Trials will comprise an initial Proof of Concept period using MSAR® and then bioMSAR™ for performance baseline tests, followed by 4,000 hours of operation (approximately 6-8 months) on bioMSAR™ in order to obtain a letter of no objection from engine manufacturer Wärtsilä upon success.

The Agreement sets out the responsibilities of Quadrise and MAC2 in respect of the Trials, which will be carried out following the installation and commissioning of Quadrise equipment at the MAC2 facility in Antwerp, Belgium in Q2 2025. MAC2 will be responsible for the supply of jetty space, utilities, permits and ad-hoc support services during the Trials, whilst Quadrise will be responsible for the provision of MSAR® and bioMSAR™ technology and fuel production equipment and personnel.

The remaining bilateral agreements to facilitate the Trials, including a toll manufacturing agreement between Cargill BV ("Cargill") and Quadrise in respect of fuel manufacture, continue to be advanced and further announcements will be made in due course.

Alongside the Trials, the parties plan to initiate commercial MSAR® and bioMSAR™ bunker supply operations to the marine sector through the MAC2 facilities in the Port of Antwerp-Bruges to MSC and other shipping companies on a permanent basis.

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

"We are pleased to have signed this services agreement with MAC2 to progress our plans for supplying MSAR® and bioMSAR™ to the marine sector from Antwerp-Bruges. We look forward to working with them as we prepare for the trials on the MSC Leandra V in Q2 2025 and to a successful longer-term partnership as we progress to commercial supply."

AKHM.. Its hard to say but if the business was just covering its running cost not very much.....

Ive invested in QED because i believe once adopted the QED tec/products can be scaled quickly and over one or 2 years its revenues should have amazing growth which will be reflected in the share price should this happen I also think the company will be in play and will be very attractive to the majors

LONO trial is expected to conclude 6-8 months following completion of the

2-month long POC tests. Approximately 10,000-12,000 tonnes of Quadrise fuels will be

consumed over the period.

Quadrise will be remunerated under the Tolling Agreement with Cargill for the trial.

Does anyone have any idea how much revenue this will generate?

Hotfinance14-OMG how will I sleep tonight

Hotfinance I agree the opportunities moving forward are mind blowing we just need the current projects to move forward now as planned...